You are subscribed to the Drug Topics Community Pharmacists' Report.

Drug Topics Community Pharmacists' Report

eNewsletter Subscribe

Print Subscribe

Digital Edition Subscribe

July 29, 2014

Web Version  |  Digital Edition  |  Share with a colleague

Facebook Like   Twitter Tweet

TODAY'S HEADLINES

Pharmacist pleads guilty in overdose death

A Montana pharmacist recently pled guilty to federal charges that he illegally distributed Vicodin and other drugs that resulted in the overdose death of a 24-year-old woman, according to the Associated Press. Ben Willard Hunn, 47, of Great Falls, faces up to 15 years in prison when U.S. District Judge Susan Watters sentences him later this year. » More

Crawford retiring from Walgreens

Kermit Crawford, employed by Walgreens in various capacities over the past three decades, is retiring as the chain's president of pharmacy, health, and wellness, the company recently announced. He has announced plans to join the University of Southern California's School of Pharmacy as executive in residence and senior advisor to the dean. » More

ADVERTISEMENT

Find the latest articles and CME on emerging oral anticoagulant therapies to assist you in meeting the healthcare challenges associated with nonvalvular atrial fibrillation. View video, read new articles, take CME and explore useful tools for your practice.
Learn More

Are pharmacies the answer for less-costly pet Rxs?

At least two U.S. senators believe so. They've promised to introduce legislation that would require veterinarians to provide written prescriptions so customers can competitively shop for pet medications. Sens. Charles Schumer (D-NY) and Richard Blumenthal (D-Conn) said pet owners are paying a 240% markup when they buy drugs from veterinarians. » More

Harder-to-abuse oxycodone painkiller approved

FDA has approved a new oxycodone painkiller designed to be more difficult for drug abusers to exploit. Targiniq ER (Purdue Pharma) is an extended-release tablet that combines oxycodone, the active ingredient in OxyContin, with the drug naloxone. It is said to be more difficult, but not impossible, to abuse. » More

Continuing Education

MTM essentials for antiplatelet therapy in cardiovascular disease

This month's article is the sixth in a year-long CPE series, Medication Therapy Management Considerations for Adult Patients with Cardiovascular Disease. From February 2014 through January 2015, pharmacists can earn up to 24 hours of CPE credit with 12 monthly knowledge-based activities from the University of Connecticut School of Pharmacy and Drug Topics.

The goal of this month's activity is to review the pharmacokinetic and pharmacodynamic differences, clinical indications, and pertinent drug-drug interactions for antiplatelet agents in cardiovascular disease.

To read and print the article with TEST QUESTIONS, click here. To proceed to the online exams and earn up to 2 CPE credits, click here to log in with the session code 14DT08-KTF27.

Announcement: Starting this month, our CE activities have moved to a new learning management system to better serve you. The login to the Online CE Center is https://web2.uconn.edu/pharmacyce/login.php. All current user registration information has been uploaded for your convenience. Current users do not need to register. To review your registration page to ensure the data is up to date or to register, go to https://web2.uconn.edu/pharmacyce/program_register.php. For a full list of courses, go to http://pharmacy.uconn.edu/academics/ce/drug-topics-and-uconn-ce/

 

Check these out, too

Pharmacy school wins $11.3 million grant

Behavior-change training for pharmacists

Health Mart's new marketing courses

New tools to improve medication adherence

Voices

Anticoagulation Update

JP at Large

View from the Zoo

Viewpoints

Regulatory and Legal

Meetings and Events

Powered by Modern Medicine Advanstar Medical Communications Group